NIH-funded research U01 cooperative agreement

Short virtual-reality test of everyday thinking and daily tasks for early Alzheimer's

Official title: Development of a Qualification Plan for the Virtual Reality Functional Capacity Assessment Tool - Short List (VRFCAT-SLx) (DDT COA #000004)

Funded at Critical Path Institute · NIH-11181561 · Data updated 2026-11-12

This project develops a short virtual-reality test to measure everyday thinking and daily tasks in people with early, biomarker-positive Alzheimer's disease.

More Virtual Reality research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCritical Path Institute
NIH-funded
Lab location1 site (Tucson, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2025
Award (this year)$249,962
NIH project number5U01FD008424-02
Project IDNIH-11181561 on NIH RePORTER

Who could benefit from this research

Could help

People with biomarker-positive early-stage Alzheimer's disease (clinical stages 2 or 3) who can use a VR headset and follow task instructions are the intended candidates.

Less likely to help

People without Alzheimer's, those with more advanced dementia, or those with severe vision, balance, or VR intolerance issues are unlikely to benefit from participating.

What this research studies

You would try a brief virtual-reality program that recreates everyday tasks (like shopping, cooking, or taking medications) while researchers record how you perform. The team is preparing a Qualification Plan to ask the FDA to recognize the VRFCAT-SLx as an official performance measure of day-to-day functioning in people with biomarker-positive clinical stages 2 and 3 Alzheimer's. They will combine interviews and other qualitative feedback with statistical testing of task scores to show the tool measures real-world abilities reliably and fairly. If you participate, you may be asked to complete VR tasks and answer questions about how realistic and understandable they felt.

Why it matters

Potential benefit: If accepted by regulators, this tool could make clinical trials better at showing whether treatments help people keep their everyday thinking and functioning, which may speed development of effective therapies.

How similar studies have gone: Performance-based VR and functional capacity tools have shown promise and VRFCAT already has prior content-validity support and is being further confirmed for regulatory qualification.

Where this research is happening

  • Critical Path Institute
    Tucson, United States
    Active

Researchers

  • Principal investigator: Eremenco, Sonya — Critical Path Institute
  • Study coordinator: Eremenco, Sonya

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.